신경혈전제거 기기 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Neurothrombectomy Devices Market Size, Share & Trends Analysis Report By Product, By End Use, By Region, And Segment Forecast, 2025 - 2030

US $ 5,950 ￦ 8,401,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,813,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,637,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

신경혈전제거 기기 시장 성장과 동향

Grand View Research, Inc.의 최신 보고서에 따르면, 세계 신경혈전제거 기기 시장 규모는 2025-2030년 동안 CAGR 6.94%를 기록하며 2030년까지 11억 달러에 달할 것으로 예상됩니다. 시장 성장은 뇌졸중 유병률 증가, 건강에 해로운 생활습관 채택 증가, 최소침습 수술에 대한 수요 증가, 시장 진입 기업의 다양한 전략적 이니셔티브 채택 등 다양한 요인에 의해 주도되고 있습니다. 기존 개두술과 비교하여 이러한 장치는 상처 봉합을 단순화하고 상처 치유를 가속화할 수 있는 이점이 있습니다. 예를 들어, 두개 내강에 쉽게 접근할 수 있고, 침습을 최소화하며, 신경혈전제거 기기와 관련된 첨단 설계 및 기능으로 어려운 시술을 간소화할 수 있습니다.

또한, 모든 연령대에서 보다 심미적이고 자연스러운 외모에 대한 관심이 증가하고 있으며, 최소침습 수술 중 출혈이 적다는 점도 시장 성장의 주요 촉진요인 중 하나입니다. 이러한 시술은 침습적 시술보다 외상을 더욱 줄이고 빠른 회복을 촉진하는 데 도움이 될 것으로 기대되고 있습니다. 이처럼 신경혈전제거 기기는 출혈이 적고 회복이 빠르기 때문에 최소침습적 수술에 대한 수요가 증가할 것으로 예상됩니다. 또한, 기술적으로 진보된 제품의 채택과 신속한 제품 승인 절차는 예측 기간 동안 시장 성장을 촉진할 것으로 예상되는 요인이며, AIS 및 관련 증상 치료를 위한 신경혈전제거 기기 개발에는 다양한 다른 기술이 사용되고 있습니다. 예를 들어, 2023년 6월 Penumbra는 Lightning Bolt7 동맥 혈전제거 시스템을 발표했습니다. 이 장치는 혈전과 혈류의 차이를 식별하는 데 도움이 됩니다.

신경혈전제거 기기 시장 보고서 하이라이트

• 제품별로는 급성 허혈성 뇌졸중 유병률 증가와 주요 시장 진입 기업의 제품 출시 증가로 인해 혈전 회수 장치가 57.8%의 점유율을 차지하며 2024년 시장을 장악했습니다.
• 최종 용도별로는 병원 부문이 의료 시설의 개선과 병원 내 첨단 장비의 가용성으로 인해 2024년 병원 부문이 70.4%의 점유율로 시장을 장악했습니다.
• 유럽은 급성 허혈성 뇌졸중 환자 증가로 인해 2024년 32.9%의 최대 매출 점유율로 시장을 주도했습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 신경혈전제거 기기 시장 변수, 동향, 범위

• 시장 소개/계통 전망
• 시장 규모와 성장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 신경혈전제거 기기 시장 분석 툴
  • Porters 분석
  • PESTEL 분석

제4장 신경혈전제거 기기 시장 : 제품별, 추정·동향 분석

• 부문 대시보드
• 신경혈전제거 기기 시장 : 제품 변동 분석, 2024년과 2030년
• 혈전 회수기
• 흡인 기기
• 혈관 스네어

제5장 신경혈전제거 기기 시장 : 최종 용도별, 추정·동향 분석

• 부문 대시보드
• 신경혈전제거 기기 시장 : 최종 용도 변동 분석, 2024년과 2030년
• 병원
• 구급 클리닉
• 외래 수술 센터

제6장 신경혈전제거 기기 시장 : 지역별, 추정·동향 분석

• 신경혈전제거 기기 시장 점유율, 지역별, 2024년과 2030년
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 덴마크
  • 스웨덴
  • 노르웨이
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 태국
  • 한국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트
  • 쿠웨이트

제7장 경쟁 구도

• 주요 시장 진출 기업의 최근 동향과 영향 분석
• 기업 분류
• 기업 히트맵 분석
• 기업 개요
  • Medtronic
  • Stryker
  • Acandis GmbH
  • Phenox GmbH
  • Penumbra
  • Vesalio, LLC.
  • Terumo Corporation
  • MIVI Neuroscience, Inc.
  • ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
  • Rapid Medical
  • Infinity Neuro

ksm

영문 목차

영문목차

Neurothrombectomy Devices Market Growth & Trends:

The global neurothrombectomy devices market size is expected to reach USD 1.1 billion by 2030, registering a CAGR of 6.94% from 2025 to 2030, according to a new report by Grand View Research, Inc. Market growth is being driven by various factors including increasing prevalence of stroke, rising adoption of unhealthy lifestyle, increasing demand for minimally invasive procedures and adoption of various strategic initiatives by market players. Compared to traditional, open surgery, these devices provide advantages that simplify wound closure and permit faster healing, such as easy access to intracranial space, minimum invasion, and simplification of challenging procedures due to advanced designs & features associated with neurothrombectomy devices.

Moreover, increasing concern for a more esthetic and natural appearance in all age groups and less amount of blood loss during minimally invasive surgeries are among the major drivers of market growth. Such procedures are expected to further help lower trauma and facilitate quicker recovery than invasive procedures. Thus, neurothrombectomy devices involve less amount of blood loss and quicker recovery time, which is expected to increase the demand for minimally invasive procedures. Moreover, introduction of technologically advanced products and rapid product approval process are factors expected to fuel market growth over the forecast period. There are various other technologies used in the development of neurothrombectomy devices for the treatment of AIS and its associated symptoms. For instance, In June 2023, Penumbra introduced their lightning Bolt7 arterial thrombectomy system. This device helps identify the difference between a blood clot and blood flow.

Neurothrombectomy Devices Market Report Highlights:

• Based on products, clot retrievers segment dominated the market in 2024, with a share of 57.8% owing to the rising prevalence of acute ischemic stroke and an increasing number of product launches by key market players.
• Based on end-use, hospital segment dominated the market in 2024 with a share of 70.4% due to improving health care facilities and the availability of advanced equipment in the hospitals.
• Europe led the market with the maximum revenue share of 32.9% in 2024, owing to the increasing number of patients suffering from acute ischemic stroke in this region.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
• 1.3. Research Methodology
  • 1.3.1. Information Procurement
  • 1.3.2. Information or Data Analysis
  • 1.3.3. Market Formulation & Data Visualization
  • 1.3.4. Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Neurothrombectomy Devices Market Variables, Trends, & Scope

• 3.1. Market Introduction/Lineage Outlook
• 3.2. Market Size and Growth Prospects (USD Million)
• 3.3. Market Dynamics
  • 3.3.1. Market Drivers Analysis
  • 3.3.2. Market Restraints Analysis
• 3.4. Neurothrombectomy Devices Market Analysis Tools
  • 3.4.1. Porter's Analysis
    • 3.4.1.1. Bargaining power of suppliers
    • 3.4.1.2. Bargaining power of buyers
    • 3.4.1.3. Threats of substitution
    • 3.4.1.4. Threats from new entrants
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political Landscape
    • 3.4.2.2. Economic and Social Landscape
    • 3.4.2.3. Technological Landscape
    • 3.4.2.4. Environmental Landscape
    • 3.4.2.5. Legal Landscape

Chapter 4. Neurothrombectomy Devices Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Neurothrombectomy Devices Market: Product Movement Analysis, 2024 & 2030 (USD Million)
• 4.3. Clot Retrievers
  • 4.3.1. Clot Retrievers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.4. Aspiration/Suction Devices
  • 4.4.1. Aspiration/Suction Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Vascular Snares
  • 4.5.1. Vascular Snares Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Neurothrombectomy Devices Market: End Use Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Neurothrombectomy Devices Market: End Use Movement Analysis, 2024 & 2030 (USD Million)
• 5.3. Hospitals
  • 5.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.4. Emergency Clinics
  • 5.4.1. Emergency Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Ambulatory Surgical Centers
  • 5.5.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Neurothrombectomy Devices Market: Regional Estimates & Trend Analysis

• 6.1. Neurothrombectomy Devices Market Share, By Region, 2024 & 2030 (USD Million)
• 6.2. North America
  • 6.2.1. North America Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.2.2. U.S.
    • 6.2.2.1. Key Country Dynamics
    • 6.2.2.2. Regulatory Landscape/Reimbursement Structure
    • 6.2.2.3. Competitive Scenario
    • 6.2.2.4. U.S. Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.2.3. Canada
    • 6.2.3.1. Key Country Dynamics
    • 6.2.3.2. Regulatory Landscape/Reimbursement Structure
    • 6.2.3.3. Competitive Scenario
    • 6.2.3.4. Canada Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.2.4. Mexico
    • 6.2.4.1. Key Country Dynamics
    • 6.2.4.2. Regulatory Landscape/Reimbursement Structure
    • 6.2.4.3. Competitive Scenario
    • 6.2.4.4. Mexico Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.3. Europe
  • 6.3.1. Europe Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.2. UK
    • 6.3.2.1. Key Country Dynamics
    • 6.3.2.2. Regulatory Landscape/Reimbursement Structure
    • 6.3.2.3. Competitive Scenario
    • 6.3.2.4. UK Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.3. Germany
    • 6.3.3.1. Key Country Dynamics
    • 6.3.3.2. Regulatory Landscape/Reimbursement Structure
    • 6.3.3.3. Competitive Scenario
    • 6.3.3.4. Germany Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.4. France
    • 6.3.4.1. Key Country Dynamics
    • 6.3.4.2. Regulatory Landscape/Reimbursement Structure
    • 6.3.4.3. Competitive Scenario
    • 6.3.4.4. France Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.5. Italy
    • 6.3.5.1. Key Country Dynamics
    • 6.3.5.2. Regulatory Landscape/Reimbursement Structure
    • 6.3.5.3. Competitive Scenario
    • 6.3.5.4. Italy Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.6. Spain
    • 6.3.6.1. Key Country Dynamics
    • 6.3.6.2. Regulatory Landscape/Reimbursement Structure
    • 6.3.6.3. Competitive Scenario
    • 6.3.6.4. Spain Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.7. Denmark
    • 6.3.7.1. Key Country Dynamics
    • 6.3.7.2. Regulatory Landscape/Reimbursement Structure
    • 6.3.7.3. Competitive Scenario
    • 6.3.7.4. Denmark Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.8. Sweden
    • 6.3.8.1. Key Country Dynamics
    • 6.3.8.2. Regulatory Landscape/Reimbursement Structure
    • 6.3.8.3. Competitive Scenario
    • 6.3.8.4. Sweden Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.9. Norway
    • 6.3.9.1. Key Country Dynamics
    • 6.3.9.2. Regulatory Landscape/Reimbursement Structure
    • 6.3.9.3. Competitive Scenario
    • 6.3.9.4. Norway Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.4. Asia Pacific
  • 6.4.1. Asia Pacific Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.2. Japan
    • 6.4.2.1. Key Country Dynamics
    • 6.4.2.2. Regulatory Landscape/Reimbursement Structure
    • 6.4.2.3. Competitive Scenario
    • 6.4.2.4. Japan Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.3. China
    • 6.4.3.1. Key Country Dynamics
    • 6.4.3.2. Regulatory Landscape/Reimbursement Structure
    • 6.4.3.3. Competitive Scenario
    • 6.4.3.4. China Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.4. India
    • 6.4.4.1. Key Country Dynamics
    • 6.4.4.2. Regulatory Landscape/Reimbursement Structure
    • 6.4.4.3. Competitive Scenario
    • 6.4.4.4. India Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.5. Australia
    • 6.4.5.1. Key Country Dynamics
    • 6.4.5.2. Regulatory Landscape/Reimbursement Structure
    • 6.4.5.3. Competitive Scenario
    • 6.4.5.4. Australia Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.6. Thailand
    • 6.4.6.1. Key Country Dynamics
    • 6.4.6.2. Regulatory Landscape/Reimbursement Structure
    • 6.4.6.3. Competitive Scenario
    • 6.4.6.4. Thailand Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.7. South Korea
    • 6.4.7.1. Key Country Dynamics
    • 6.4.7.2. Regulatory Landscape/Reimbursement Structure
    • 6.4.7.3. Competitive Scenario
    • 6.4.7.4. South Korea Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Latin America
  • 6.5.1. Latin America Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.2. Brazil
    • 6.5.2.1. Key Country Dynamics
    • 6.5.2.2. Regulatory Landscape/Reimbursement Structure
    • 6.5.2.3. Competitive Scenario
    • 6.5.2.4. Brazil Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.3. Argentina
    • 6.5.3.1. Key Country Dynamics
    • 6.5.3.2. Regulatory Landscape/Reimbursement Structure
    • 6.5.3.3. Competitive Scenario
    • 6.5.3.4. Argentina Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Middle East and Africa
  • 6.6.1. Middle East and Africa Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.2. South Africa
    • 6.6.2.1. Key Country Dynamics
    • 6.6.2.2. Regulatory Landscape/Reimbursement Structure
    • 6.6.2.3. Competitive Scenario
    • 6.6.2.4. South Africa Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.3. Saudi Arabia
    • 6.6.3.1. Key Country Dynamics
    • 6.6.3.2. Regulatory Landscape/Reimbursement Structure
    • 6.6.3.3. Competitive Scenario
    • 6.6.3.4. Saudi Arabia Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.4. UAE
    • 6.6.4.1. Key Country Dynamics
    • 6.6.4.2. Regulatory Landscape/Reimbursement Structure
    • 6.6.4.3. Competitive Scenario
    • 6.6.4.4. UAE Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.5. Kuwait
    • 6.6.5.1. Key Country Dynamics
    • 6.6.5.2. Regulatory Landscape/Reimbursement Structure
    • 6.6.5.3. Competitive Scenario
    • 6.6.5.4. Kuwait Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis by Key Market Participants
• 7.2. Company Categorization
• 7.3. Company Heat Map Analysis
• 7.4. Company Profiles
  • 7.4.1. Medtronic
    • 7.4.1.1. Participant's Overview
    • 7.4.1.2. Financial Performance
    • 7.4.1.3. Product Benchmarking
    • 7.4.1.4. Recent Developments/ Strategic Initiatives
  • 7.4.2. Stryker
    • 7.4.2.1. Participant's Overview
    • 7.4.2.2. Financial Performance
    • 7.4.2.3. Product Benchmarking
    • 7.4.2.4. Recent Developments/ Strategic Initiatives
  • 7.4.3. Acandis GmbH
    • 7.4.3.1. Participant's Overview
    • 7.4.3.2. Financial Performance
    • 7.4.3.3. Product Benchmarking
    • 7.4.3.4. Recent Developments/ Strategic Initiatives
  • 7.4.4. Phenox GmbH
    • 7.4.4.1. Participant's Overview
    • 7.4.4.2. Financial Performance
    • 7.4.4.3. Product Benchmarking
    • 7.4.4.4. Recent Developments/ Strategic Initiatives
  • 7.4.5. Penumbra
    • 7.4.5.1. Participant's Overview
    • 7.4.5.2. Financial Performance
    • 7.4.5.3. Product Benchmarking
    • 7.4.5.4. Recent Developments/ Strategic Initiatives
  • 7.4.6. Vesalio, LLC.
    • 7.4.6.1. Participant's Overview
    • 7.4.6.2. Financial Performance
    • 7.4.6.3. Product Benchmarking
    • 7.4.6.4. Recent Developments/ Strategic Initiatives
  • 7.4.7. Terumo Corporation
    • 7.4.7.1. Participant's Overview
    • 7.4.7.2. Financial Performance
    • 7.4.7.3. Product Benchmarking
    • 7.4.7.4. Recent Developments/ Strategic Initiatives
  • 7.4.8. MIVI Neuroscience, Inc.
    • 7.4.8.1. Participant's Overview
    • 7.4.8.2. Financial Performance
    • 7.4.8.3. Product Benchmarking
    • 7.4.8.4. Recent Developments/ Strategic Initiatives
  • 7.4.9. ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
    • 7.4.9.1. Participant's Overview
    • 7.4.9.2. Financial Performance
    • 7.4.9.3. Product Benchmarking
    • 7.4.9.4. Recent Developments/ Strategic Initiatives
  • 7.4.10. Rapid Medical
    • 7.4.10.1. Participant's Overview
    • 7.4.10.2. Financial Performance
    • 7.4.10.3. Product Benchmarking
    • 7.4.10.4. Recent Developments/ Strategic Initiatives
  • 7.4.11. Infinity Neuro
    • 7.4.11.1. Participant's Overview
    • 7.4.11.2. Financial Performance
    • 7.4.11.3. Product Benchmarking
    • 7.4.11.4. Recent Developments/ Strategic Initiatives

관련자료